Clinical Trial Update: Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients

View source ↗

Summary

An update on a clinical trial comparing the metabolic safety of raltegravir versus darunavir in treatment-naive HIV patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Drugs mentioned

• Darunavir (darunavir)
• Raltegravir (raltegravir)

Snippet

Sponsor: Hospital Carlos III, Madrid | Conditions: Cardiovascular Disease, HIV Infections | Status: UNKNOWN